Absci
Yahoo Finance • 2 months ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood is having a rough year as the co-founder, CEO and investment manager of Ark Invest. Her largest exchange-traded fund is trading 15% lower this year, a rough contrast to a winning year for many growth investors. She's not giving... Full story
Yahoo Finance • 12 months ago
Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference
VANCOUVER, Wash. and NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Piper Sandler 35th Annual Healthc... Full story
Yahoo Finance • 12 months ago
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
Entered into partnership with Almirall to rapidly develop novel treatments for dermatological diseases, for up to $664M in deal value, plus royalties Unveiled AI drug creation pipeline of four wholly-owned assets VANCOUVER, Wash. and NEW... Full story
Yahoo Finance • 12 months ago
Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases
VANCOUVER, Wash. and BARCELONA, Spain, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on medical dermato... Full story
Yahoo Finance • last year
Absci to Participate in Upcoming Investor Conferences
VANCOUVER, Wash. and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences in... Full story
Yahoo Finance • last year
Absci to Host R&D Day on October 4, 2023
VANCOUVER, Wash. and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will host its first R&D Day on Wednesday, October 4th, 2023 in New Yor... Full story
Yahoo Finance • last year
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
Entered into partnership with Google Ventures-backed biotech company to discover innovative new medicines Entered into collaboration with Caltech, supported by the Gates Foundation, to discover affordable HIV therapeutic vaccinations VAN... Full story
Yahoo Finance • last year
Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer
VANCOUVER, Wash., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Absci Corporation, a generative AI drug creation company, announced today that Zach Jonasson, Ph.D., has been appointed Chief Financial Officer (CFO) and Chief Business Officer (CBO). I... Full story
Yahoo Finance • last year
Absci to Participate in the Morgan Stanley 2nd Annual Biotechnology AI Summit
VANCOUVER, Wash. and NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 2nd Annual Biotech... Full story
Yahoo Finance • last year
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
Commenced work plan preparations and expect to initiate program work during second quarter leveraging Absci's generative AI drug creation platform for Phase II candidate Achieved rapid advancements of generative AI drug creation platform,... Full story
Yahoo Finance • last year
University of Oxford’s Kennedy Institute of Rheumatology Partners with Absci to Accelerate AI-Driven Immunotherapies
VANCOUVER, Wash. and OXFORD, UK, May 11, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and the University of Oxford’s Kennedy Institute of Rheumatology, a biomedical research center dev... Full story
Yahoo Finance • 2 years ago
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
VANCOUVER, Wash. and NEW YORK, April 06, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 22nd Annual Needham Virtual Heal... Full story
Yahoo Finance • 2 years ago
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
VANCOUVER, Wash. and TAMPA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, and M2GEN, an oncology bioinformatics company with the most advanced lifetime-consented clinico... Full story
Yahoo Finance • 2 years ago
Absci to Participate in the B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation
VANCOUVER, Wash. and NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming B. Riley Securities' L... Full story
Yahoo Finance • 2 years ago
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
VANCOUVER, Wash. and NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating virtually in the upcoming KeyBanc Capital Market... Full story
Yahoo Finance • 2 years ago
Absci Expands in Europe with Launch of New Innovation Center and Additional Senior Leadership in Switzerland
VANCOUVER, Wash. and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced its expansion into the European pharmaceutical market with the opening of its Innov... Full story
Yahoo Finance • 2 years ago
Absci to Participate in the 43rd Annual Cowen Health Care Conference
VANCOUVER, Wash. and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming 43rd Annual Cowen Health Care Con... Full story
Yahoo Finance • 2 years ago
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
Absci’s generative AI and wet lab capabilities combined with St. John’s Cancer Institute’s molecular database of cancer patient specimens will accelerate the development of immunotherapies. VANCOUVER, Wash. and NEW YORK, Feb. 09, 2023 (... Full story
Yahoo Finance • 2 years ago
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
VANCOUVER, Wash. and NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific le... Full story
Yahoo Finance • 2 years ago
10 Penny Stocks That Will Make You A Millionaire
In this article, we will discuss the 10 penny stocks that will make you a millionaire. If you want to explore similar stocks, you can also take a look at 5 Penny Stocks That Will Make You A Millionaire. Penny stocks can be an attractive o... Full story
